• 743 Citations
  • 8 h-Index
19992018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maiko Matsushita is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Leukemia Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

  • 743 Citations
  • 8 h-Index
  • 24 Article
  • 1 Review article

A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress

Okayama, M., Kitabatake, S., Sato, M., Fujimori, K., Ichikawa, D., Matsushita, M., Suto, Y., Iwasaki, G., Yamada, T., Kiuchi, F., Hirao, M., Kunieda, H., Osada, M., Okamoto, S. & Hattori, Y., 2018 Nov 2, In : Biochemical and Biophysical Research Communications. 505, 3, p. 787-793 7 p.

Research output: Contribution to journalArticle

Endoplasmic Reticulum Stress
Biological Products
Multiple Myeloma
Apoptosis
Oxygen
1 Citation (Scopus)

Anticancer Drug Prescription Patterns in Japan: Future Directions in Cancer Therapy

Shibata, S., Matsushita, M., Saito, Y. & Suzuki, T., 2018 Nov 1, In : Therapeutic Innovation and Regulatory Science. 52, 6, p. 718-723 6 p.

Research output: Contribution to journalArticle

Drug Prescriptions
Japan
Pharmaceutical Preparations
Neoplasms
Health Expenditures
2 Citations (Scopus)

Immunomodulatory Effects of Drugs for Effective Cancer Immunotherapy

Matsushita, M. & Kawaguchi, M., 2018 Jan 1, In : Journal of Oncology. 2018, 8653489.

Research output: Contribution to journalReview article

Immunotherapy
Pharmaceutical Preparations
Neoplasms
Immunity
Hydroxymethylglutaryl-CoA Reductase Inhibitors

An empirical study of the prescription pattern of drugs for hematological malignancies in Japan from 2010-2014

Shibata, S., Wayama, Y., Tsuyuki, A., Matsushita, M., Chiba, K., Matsuki, E., Okamoto, S. & Suzuki, T., 2017, In : Biological and Pharmaceutical Bulletin. 40, 6, p. 894-901 8 p.

Research output: Contribution to journalArticle

Prescription Drugs
Hematologic Neoplasms
Japan
Pharmaceutical Preparations
Pharmaceutical Databases

A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest

Aida, S., Hozumi, M., Ichikawa, D., Iida, K., Yonemura, Y., Tabata, N., Yamada, T., Matsushita, M., Sugai, T., Yanagawa, H. & Hattori, Y., 2017, (Accepted/In press) In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journalArticle

G2 Phase Cell Cycle Checkpoints
Pharmacokinetics
Multiple Myeloma
Polyethylene glycols
Cells